Abstract:To study the clinical correlation between fasting plasma glucose, lipid metabolism, prostate-specific antigen and prostate volume in patients with benign prostatic hyperplasia, and to explore the combined effect as diagnostic indicators. A total of 108 patients with benign prostatic hyperplasia treated in Beijing University of Chinese Medicine Third Affiliated Hospital from June 2021 to March 2023 were retrospectively analyzed as the hyperplasia group, and 98 healthy physical examination personnel were selected as the control group during the same period. Compare the differences in levels of fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), small and dense low-density lipoprotein cholesterol (sdLDL-C), homocysteine, lipoprotein a (LPa), prostate specific antigen (PSA), and free prostate specific antigen (fPSA) between two groups of patients. Using Pearson analysis method to analyze the correlation between the above indicators and the size of prostate volume in patients with benign prostatic hyperplasia; using multiple linear regression to analyze the influencing factors of prostate volume enlargement; draw receiver operating characteristic (ROC) curves and analyze the application value of individual and combined detection of HDL, FPG, PSA, and fPSA. The results showed that there were significant differences in HDL, FPG, PSA, and fPSA levels between the control group and the proliferative group(P<0.05). The size of prostate volume is negatively correlated with HDL(r=-0.183, P<0.05) and positively correlated with FPG (r=0.202, P<0.05), PSA(r=0.412, P<0.05), and fPSA(r=0.425, P<0.05). The results of multiple linear regression analysis showed that HDL(P=0.000), FPG(P=0.048), PSA(P=0.044), and fPSA (P=0.012) were risk factors for increased volume of benign prostatic hyperplasia; ROC curve analysis shows that the AUC of HDL, FPG, PSA, and fPSA combined detection is 0.823, which is better than individual detection. In conclusion,HDL, FPG, PSA, fPSA has close correlation with hyperplasia of prostate, the joint detection may has better prediction for benign prostatic hyperplasia.

Comparing Clinical Parameters of Abnormal and Normal Fasting Blood Glucose in Benign Prostatic Hyperplasia Patients.

Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients.

Fasting Blood Glucose Level and Hypertension Risk in Aging Benign Prostatic Hyperplasia Patients.

Relationship between diabetes mellitus and benign prostatic hyperplasia

Correlation of Diabetes Control with Benign Prostatic Hyperplasia in T2DM Patients

The Relationship Between Glucose Homeostasis Status and Prostate Size in Aging Chinese Males with Benign Prostatic Hyperplasia

Relationship Between Serum Sex Hormones Levels and Degree of Benign Prostate Hyperplasia in Chinese Aging Men

Correlation Between Metabolic Syndrome and Clinical Progression in Patients with Benign Prostatic Hyperplasia

The Relationship between Blood Glucose and Prostate Cancer Patients

[Study on the correlation between glycolipids and prostate volume in patients with benign prostatic hyperplasia]

[Correlation of Benign Prostatic Hyperplasia with Hyperlipemia].

The Association Between Insulin Resistance and Prostatic Hyperplasia

Relationship between metabolic syndrome and benign prostatic hyperplasia

Relationship Between Benign Prostatic Hyperplasia and Metabolic Syndrome

The Correlation Between Metabolic Syndrome and Benign Prostatic Hyperplasia in Men over 50 Years O1d

Clinical study the relationship between symptomatic parameters of benign prostate hyperplasia and sexual function

Correlation between Hyperuricemia and Benign Prostatic Hyperplasia

Correlation between Benign Prostatic Hyperplasia and Metabolic Syndrome

The Relationship Between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study

A Preliminary Study of the Impact of Insulin Resistance on the Growth of the Prostate in Patients with Benign Prostatic Hyperplasia

Metabolic profile in patients with prostate cancer